Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
about
Energy expenditure estimation in beta-blocker-medicated cardiac patients by combining heart rate and body movement data.Evaluating the effect of a web-based quality improvement system with feedback and outreach visits on guideline concordance in the field of cardiac rehabilitation: rationale and study protocol.Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study.Ischemic heart disease diagnosed before sudden cardiac arrest is independently associated with improved survival.The Gold Standard Program for smoking cessation is effective for participants over 60 years of age.The effectiveness of mobile-health behaviour change interventions for cardiovascular disease self-management: A systematic review.Present and future of secondary prevention after an acute coronary syndrome.Improving guideline concordance in multidisciplinary teams: preliminary results of a cluster-randomized trial evaluating the effect of a web-based audit and feedback intervention with outreach visits.Exercise training programs in Dutch cardiac rehabilitation centres.Exercise training characteristics in cardiac rehabilitation programmes: a cross-sectional survey of Australian practiceEffect of continuous care model on lifestyle of patients with myocardial infarction.The Nurse-Led Telephone Follow-Up on Medication and Dietary Adherence among Patients after Myocardial Infarction: A Randomized Controlled Clinical Trial.Green tea and exercise interventions as nondrug remedies in geriatric patients with rheumatoid arthritis.Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study.Trends in incidence and outcome of out-of-hospital cardiac arrest among people with validated myocardial infarction.Sense of coherence as a predictor of health-related behaviours among patients with coronary heart disease.Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry.Psychosocial interventions in cardiovascular disease – what are they?Nichtmedikamentöse Sekundärprävention der koronaren Herzkrankheit
P2860
Q31130576-13F34ABF-8AEA-46E7-8979-652ABB4BAF72Q34984649-4D655872-8E1F-4A1F-9E5E-AC3925FAEB77Q35011164-677DAFFC-F246-4B3F-A1B6-37E8D896507BQ35070846-129A5BEE-322B-4CDF-806A-2BF37D1B8AF8Q35228000-D6D38846-61B0-4845-941A-1870F2FD8D13Q35816630-FEAE55F3-2A7B-454B-9D18-9AE63DF7C3F1Q36118008-1EBA94B8-DCEC-4C38-B1A8-1333FCFEF5E6Q36613225-466F33F3-AABA-490F-B51E-E35F67DD91FAQ36627302-8E8AD9CE-A2CC-42D5-A14B-F8E6519FFDFAQ36841964-CE7C8964-7D59-4DF0-A9ED-5732A06C95C8Q36925519-8309D8F4-F9D3-430D-B1B2-B0AC3856E163Q37049472-4C56D0B4-0F1C-4D37-BB6A-D0B36FF5B421Q37382183-C535740B-0B7D-4464-AF2E-FE6346763B0FQ38492804-AFA68404-0CA7-4F91-AB02-949DC8E21D95Q40845508-43020588-FF00-4338-B530-D7E9631D32E7Q41070555-A501CE38-57A1-4ECB-A8CA-BC04C008751FQ43496849-D0F93695-CD2F-49A2-AEF8-3210F344F9FFQ44671214-6F377692-1D91-486E-B159-B1C5BE788AE5Q51149698-562E5B4B-C3E4-493B-87D4-8828E20FE685Q56334776-F82A7C45-25BF-4CFF-B5ED-D5D239D99F9CQ56985369-F00D3568-7A46-4408-8A0B-F2949E6AFBEA
P2860
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@en
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@nl
type
label
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@en
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@nl
prefLabel
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@en
Effectiveness of nonpharmacological secondary prevention of coronary heart disease.
@nl
P2093
P2860
P1476
Effectiveness of nonpharmacological secondary prevention of coronary heart disease
@en
P2093
Angelina Bockelbrink
Charlotte Meinhard
Christoph Vauth
Kathrin Damm
Stefan N Willich
Wolfgang Greiner
P2860
P304
P356
10.1097/HJR.0B013E32833A1C95
P577
2010-12-01T00:00:00Z